MiR-6924-5p-rich exosomes derived from genetically modified Scleraxis-overexpressing PDGFRα(+) BMMSCs as novel nanotherapeutics for treating osteolysis during tendon-bone healing and improving healing strength
2021 · Biomaterials · 60 citations
https://doi.org/10.1016/j.biomaterials.2021.121242